Model | No. (%) with access revision within 1 year | Hazard ratio (95 % CI) for loss of patency, SLE-attributed vs. other ESRD | ||
---|---|---|---|---|
Unadjusted | Adjusted for demographics | Adjusted for demographics + clinical | ||
All patients | ||||
SLE-attributed ESRD | 21 (43.8 %) | 0.70 (0.45-1.09) | 0.81 (0.52-1.26) | 0.88 (0.57-1.37) |
Other ESRD | 7,169 (55.0 %) | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) |
P | 0.12 | 0.11 | 0.35 | 0.58 |
Among patients with AVFb | ||||
SLE-attributed ESRD | 19 (44.2 %) | 0.74 (0.46-1.17) | 0.86 (0.54-1.37) | 0.94 (0.59-1.50) |
Other ESRD | 5,735 (52.9 %) | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) |
P | 0.26 | 0.20 | 0.53 | 0.80 |
Among patients with AVGb | ||||
SLE-attributed ESRD | —c | 0.54 (0.13-2.15) | 0.57 (0.14-2.30) | 0.61 (0.15-2.47) |
Other ESRD | 1,434 (65.8 %) | 1.00 (ref.) | 1.00 (ref.) | 1.00 (ref.) |
P | 0.35 | 0.38 | 0.43 | 0.49 |